INNV - Innovus Pharmaceuticals, Inc. Stock Price, Fair Value and News

$4.74+0.11 (+2.38%)

Delayed as of 22 Nov 2024, 10:03 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

INNV Price Action

Last 7 days

-12.6%

Last 30 days

-21.7%

Last 90 days

-26.9%

Trailing 12 Months

-16.4%

INNV RSI Chart

INNV Valuation

Market Cap

627.2M

Price/Earnings (Trailing)

-39.29

Price/Sales (Trailing)

0.8

Price/Free Cashflow

-33.06

INNV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

INNV Fundamentals

INNV Revenue

Revenue (TTM)

786.5M

Rev. Growth (Yr)

12.42%

Rev. Growth (Qtr)

2.88%

INNV Earnings

Earnings (TTM)

-16.0M

Earnings Growth (Yr)

52.16%

Earnings Growth (Qtr)

-189.94%

INNV Profitability

Return on Equity

-5.93%

Return on Assets

-3.02%

Free Cashflow Yield

-3.03%

INNV Investor Care

Buy Backs (1Y)

0.32%

Diluted EPS (TTM)

-0.12

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	741.3M	763.9M	786.5M	0
2023	684.1M	688.1M	699.4M	720.8M
2022	697.4M	698.6M	696.8M	688.9M
2021	620.1M	637.8M	658.3M	676.3M
2020	0	567.2M	584.8M	602.5M

Get all data in R, Python etc through our Historical Stock Data APIs

About Innovus Pharmaceuticals, Inc.

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

CEO	Mr. Patrick Blair
WEBSITE	innovage.com
SECTOR	Healthcare
INDUSTRY	Medical Care Facilities

Innovus Pharmaceuticals, Inc. Frequently Asked Questions

What is the ticker symbol for Innovus Pharmaceuticals, Inc.? What does INNV stand for in stocks?

INNV is the stock ticker symbol of Innovus Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Innovus Pharmaceuticals, Inc. (INNV)?

As of Thu Nov 21 2024, market cap of Innovus Pharmaceuticals, Inc. is 627.16 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INNV stock?

You can check INNV's fair value in chart for subscribers.

Is Innovus Pharmaceuticals, Inc. a good stock to buy?

The fair value guage provides a quick view whether INNV is over valued or under valued. Whether Innovus Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Innovus Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INNV.

What is Innovus Pharmaceuticals, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Nov 21 2024, INNV's PE ratio (Price to Earnings) is -39.29 and Price to Sales (PS) ratio is 0.8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INNV PE ratio will change depending on the future growth rate expectations of investors.